Influence of Diet on Pregnancy With Polyhydramnios
The Influence of a Diet Suited for Gestational Diabetes on Amniotic Fluid Index in Patients Diagnosed With Idiopathic Polyhydramnios - a Randomized Controlled Trial
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
To evaluate the effect of a diet that is suited for gestational diabetes mellitus on amniotic fluid index in women with idiopathic polyhydramnios.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2020
CompletedFirst Posted
Study publicly available on registry
August 4, 2020
CompletedStudy Start
First participant enrolled
March 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2022
CompletedMarch 4, 2021
March 1, 2021
1.8 years
July 29, 2020
March 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Amniotic fluid index (AFI) after 2 weeks
AFI as measured in ultrasound
Assess AFI two weeks after diet initiation
Study Arms (2)
Control
NO INTERVENTIONDiet
EXPERIMENTALInterventions
Diet that consists of complex carbohydrates, and a regimen that includes 6 meals per day, as tailored gor gestational diabetes.
Eligibility Criteria
You may qualify if:
- Pregnant women between 24-37 pregnancy weeks, singleton pregnancy, diagnosed with AFI at 95% or more by gestational age
- Express their consent to participate in the study and try to make the recommended dietary change for at least two consecutive weeks from the moment the guidelines are given.
- Without a medical indication for an immediate delivery
You may not qualify if:
- Medical recommendation for delivery within two weeks of diagnosis
- Condition of non-idiopathic amniotic fluid: gestational or pre-gestational diabetes, fetal malformation, proof of fetal infection
- Premature rupture or membranes
- Twins pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liliya Tamayev, MD
Wolfson Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 29, 2020
First Posted
August 4, 2020
Study Start
March 20, 2021
Primary Completion
December 20, 2022
Study Completion
December 20, 2022
Last Updated
March 4, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share